People with knee arthritis and type 2 diabetes who take GLP-1 drugs (like Ozempic) may be less likely to need knee surgery—only 1.7% did, compared to 5.9% who didn’t take the drugs, over about 8 years.
See the scientific wording
In patients with knee osteoarthritis and type 2 diabetes, the use of GLP-1 receptor agonists is associated with a 4.2% absolute reduction in the risk of undergoing knee surgery (1.7% vs 5.9%) over a mean follow-up period of 7.8 years, with an adjusted hazard ratio indicating a strong inverse association between GLP-1 receptor agonist exposure and the likelihood of surgical intervention.
Correlational — new studies may shift this
ObservationalOne good-quality study links this claim to the outcome, but causation is not established.
What the research says
1 study reviewedSupporting (1)
Cohort StudyHuman2023
The study found that diabetic patients with knee arthritis who took GLP-1RAs were much less likely to need knee surgery over nearly 8 years, and this matches the claim.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
People with knee arthritis and type 2 diabetes who take GLP-1 drugs (like Ozempic) may be less likely to need knee surgery—only 1.7% did, compared to 5.9% who didn’t take the drugs, over about 8 years.
Evidence from Studies
Supporting (1)
Community contributions welcome
The study found that diabetic patients with knee arthritis who took GLP-1RAs were much less likely to need knee surgery over nearly 8 years, and this matches the claim.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of GLP-1 Receptor Agonists and Risk of Knee Surgery in Patients with Knee Osteoarthritis and Type 2 Diabetes
Comprehensive review of longitudinal studies and RCTs evaluating GLP-1RA use in adults with knee osteoarthritis and type 2 diabetes, measuring incidence of knee surgery over ≥5 years.
Randomized Controlled Trial of Semaglutide vs Placebo on Knee Surgery Incidence in Diabetic Osteoarthritis Patients
Double-blind, placebo-controlled trial assigning patients with knee osteoarthritis and type 2 diabetes to GLP-1RA or placebo, tracking knee surgery rates over 7.8 years.
Prospective Cohort Study of GLP-1RA Use and Knee Surgery Risk in Adults with Type 2 Diabetes and Knee Osteoarthritis
Longitudinal cohort of patients with both conditions, comparing surgery rates between users and non-users of GLP-1RAs over 7.8 years with multivariable adjustment.
Case-Control Study of GLP-1RA Exposure in Diabetic Osteoarthritis Patients Who Underwent Knee Surgery vs Those Who Did Not
Matched case-control study comparing prior GLP-1RA use in patients with knee osteoarthritis and type 2 diabetes who had surgery (cases) vs those who did not (controls).
Cross-Sectional Analysis of GLP-1RA Use and History of Knee Surgery in Patients with Type 2 Diabetes and Knee Osteoarthritis
Survey or database analysis of patients with both conditions, assessing prevalence of knee surgery in relation to GLP-1RA exposure history.